FIELD: organic synthesis. SUBSTANCE: invention provides novel carboxylic acid derivatives having general formula I: (I) and containing heterocyclic moieties. Compound possess biological activity, in particular they inhibit binding of endothelin to receptors and can be used for treatment of hypertension, myocardial infarction, renal insufficiency, and other maladies. In the formula I, (i) R1 denotes tetrazole, nitrile, carboxylic group, group COOR7, in which R7 is C1-C4-alkyl or alkali of alkaliearth cation, group -CONHSO2R8, in which R8 is C1-C4-alkyl, or group -CONHSO2R9, in which R9 is C1-C4-alkyl; (ii) R2 denotes hydroxy group, amino group, di-C1-C4- alkylaino group, or C1-C4-alkoxy group; (iii) X denotes nitrogen or radical CR10, in which R10 is hydrogen or C1-C5- alkyl, or CR10 and CR3 together form 5- or 6-membered alkylene or alkenylene ring optionally substituted by 1 or 2 C1- C4-alkyl group and in which one methylene group can be substituted by oxygen, imino or C1-C4-imino group; (iv) R3 denotes mono- or di-C1-C4-alkyl group, C1- C4-alkyl, C1-C4-alkoxy, or CR3 together with CR10 form above-described ring; (v) R4 and R5 each denote phenyl optionally substituted by halogen, C1-C4-alkyl or C1-C4-alkoxy, provided that two phenyls are in ortho-position to each other and linked by an ordinary linkage, methylene or ethylene group, or C3- C7- cycloalkyl group; (vi) R6 denotes C1-C8-alkyl or C3-C6-alkenyl optionally substituted by halogen, cyano, C1-C4- alkoxy, C1-C4-alkylthio, or phenyl; phenyl optionally substituted by one or two groups selected from halogen, C1-C4- alkyl, C1-C4-alkoxyl; cycloalkyl optionally substituted by C1-C4-alkyl; or five- or six-membered heterocyclic residue containing one sulfur or oxygen atom and optionally substituted by C1-C4-alkyl; and (vii) Z denotes sulfur, oxygen, sulfinyl or sulfonyl. EFFECT: extended choice of drugs. 3 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
CARBOXYLIC ACID DERIVATIVES | 1996 |
|
RU2175315C2 |
DERIVATIVES OF PYRIMIDINE- AND TRIAZINE CARBOXYLIC ACIDS FOR USE AS DRUGS | 1995 |
|
RU2163808C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
THROMBIN INHIBITORS AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS | 1995 |
|
RU2172741C2 |
ALKOXIMINOACETIC ACID AMIDES, FUNGICIDE AGENT BASED ON THEREOF AND METHOD OF CONTROL OF FUNGAL DISEASES IN PLANTS | 1996 |
|
RU2167853C2 |
PYRAZINE DERIVATIVES AND THEIR ACID-ADDITIVE SALTS | 1992 |
|
RU2124008C1 |
HETEROCYCLIC DERIVATIVES OF CARBOXYLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1994 |
|
RU2145959C1 |
N-SUBSTITUTED 3-AZABICYCLO [3 | 1993 |
|
RU2120439C1 |
PYRIDAZINE[4',5':3,4]PYRROLO[2,1-a]ISOQUINOLINE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS WITH ACIDS AND COMPLEXING AGENTS | 1994 |
|
RU2138499C1 |
TRIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2167869C2 |
Authors
Dates
2002-03-10—Published
1995-10-07—Filed